Tropisetron (Navoban) compared with alizapride in the control of emesis induced by cyclophosphamide-containing regimens.
De Nigris
A
A
Paladini
G
G
Giosa
F
F
Sfeir
C
C
Pagan
M G
MG
Maltoni
C
C
D000932:Antiemetics / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D009325:Nausea / Q000517:prevention & control*; D011759:Pyrrolidines / Q000627:therapeutic use; D000077526:Tropisetron; D014839:Vomiting / Q000517:prevention & control*
D000932:Antiemetics; D007211:Indoles; D011759:Pyrrolidines; D000077526:Tropisetron; D003520:Cyclophosphamide; C033968:alizapride